Stock Events

Stock Events

SPDR Biotech

M$1,671.6

200

+M$21.2+1.28% Tuesday 19:30

Statistics

Day High

1,679.9

Day Low

1,665

52W High

1,758

52W Low

1,109.52

Volume

2,359

Avg. Volume

197

Mkt Cap

-

P/E Ratio

-

Dividend Yield

0.49%

Dividend

8.24

Upcoming

Dividends

0.49%Dividend Yield

10Y Growth

-3.68%

5Y Growth

139.67%

3Y Growth

95.81%

1Y Growth

2,083.37%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XBI.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares Nasdaq Biotechnology ETF is a direct competitor, focusing on biotechnology and pharmaceuticals listed on the NASDAQ, similar to XBI's focus on the biotech sector.

VanEck Vectors Biotech ETF specifically targets the biotech industry, making it a close competitor to XBI with a focus on large-cap biotech companies.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund is another biotech-focused ETF, competing with XBI by investing in companies across various market caps in the biotech sector.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF competes with XBI by investing in biotech and genome companies, offering a dynamic approach to the biotech industry.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF focuses on small- and mid-cap companies in the biotech and pharmaceutical sectors, competing with XBI's broader biotech focus.

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares offers leveraged exposure to the biotechnology sector, competing with XBI by targeting similar companies but with a leveraged approach.

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares is the inverse of LABU, offering leveraged inverse exposure to the biotech sector, and competes with XBI by targeting investors looking for inverse biotech exposure.

Principal Healthcare Innovators

Principal Healthcare Innovators Index ETF focuses on early-stage small- and mid-cap healthcare companies, including biotech, competing with XBI's investment in biotech innovation.

Virtus LifeSci Biotech Products

Virtus LifeSci Biotech Products ETF competes with XBI by focusing on companies with one or more drugs in Phase II or Phase III FDA clinical trials, targeting a specific niche within the biotech sector.

Virtus LifeSci Biotech Clinical Trials

Virtus LifeSci Biotech Clinical Trials ETF is similar to BBP but focuses on companies in clinical trials, making it a competitor to XBI by targeting a specific investment strategy within the biotech industry.

About

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Show more...

CEO

ISIN

US78464A8707

Listings